Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
YS Biopharma to Report First Quarter Fiscal Year 2024 Financial Results on August 15, 2023
2023-08-11 04:30
AffaMed Therapeutics Announces Partner Vistagen Reports Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder
2023-08-10 15:49
Pfizer's Pneumococcal 20-Valent Conjugate Vaccine is Now Available in Hong Kong, For Adults Aged 18 Years or Older[1]
2023-08-10 14:15
Pharming announces first patient enrolled in Phase III clinical trial of leniolisib for the treatment of APDS in Japan
2023-08-09 13:00
Everest Medicines to Announce First Half 2023 Financial Results on August 24, 2023
2023-08-09 08:06
Lynk Pharmaceuticals Announced Positive Topline Data from Phase II Clinical Trial of LNK01001 in the Treatment of Atopic Dermatitis
2023-08-09 08:00
Race Strategic Update August 2023
2023-08-09 07:30
Innovent Announces the Preclinical Results of IBI363 (PD-1/IL-2 Bispecific Antibody Fusion Protein) were Published in Nature Cancer
2023-08-08 11:03
Pfizer Malaysia, Sunway Medical Centre Velocity and Sunway Multicare Pharmacy Collaborate to Raise Awareness on the Importance of Early Detection of Atrial Fibrillation
2023-08-08 09:00
First Patient Dosed in IPAX-2 Study of TLX101 Brain Cancer Therapy Candidate in Patients with Newly Diagnosed Glioblastoma
2023-08-08 06:24
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer
2023-08-07 21:42
6-Month Registered Clinical Trial Data on World's First Transbronchial Pulmonary Radiofrequency Ablation System for Lung Cancer Announced, Showing Significant Efficacy
2023-08-07 20:41
Avance Clinical Earns Frost & Sullivan's 2023 Best Practices Customer Value Leadership Award for Delivering High-quality Clinical Trials Based on Globally Accepted Data
2023-08-07 08:00
AI+ Media Development Platform AlfaOPA™ Officially Launched
2023-08-04 11:13
SayHeart Announces AI-Powered Visual-to-Text Transformation Pilot Testing for Dental X-Rays, with Kindlehouse Dentistry Partnership
2023-08-03 12:40
Interest in Ayurvedic beauty surges, but 1 in 5 Indian consumers find it old-fashioned
2023-08-03 12:30
Unlocking the Power of Genetics: Camtech Unveils DNA Self-Test Kits for Holistic Wellness
2023-08-02 14:42
Selected for oral presentation! Kelun-Biotech to announce latest clinical study results of SKB264 (MK-2870, TROP2-ADC) for treatment of HR+/HER2- breast cancer at ESMO Congress 2023
2023-08-01 21:07
Everest Medicines Announces Completion of Patient Enrollment in Nefecon® China Open Label Extension Study
2023-08-01 08:47
Transcenta Anti-sclerostin Monoclonal Antibody TST002 (Blosozumab) Received Approval from China CDE to Initiate Phase II Clinical Trial in Patients with Reduced Bone Mineral Density
2023-07-31 08:10
1
25
26
27
28
29
229